Search clinical trials for: HER2 Positive Solid Tumor
Total 44180 results
-
Beijing 302 HospitalRecruiting
-
Triumvira Immunologics, Inc.Merck Sharp & Dohme LLCActive, not recruitingHER2 Positive Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerUnited States, Canada
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Shanghai Miracogen Inc.RecruitingBreast Cancer With Liver MetastasesChina
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Biliary Tract CancerChina
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoRecruitingGastric CancerChina, Spain, Korea, Republic of, Canada, Italy, Poland, Japan, United Kingdom, Brazil, Taiwan, United States, Germany, Netherlands, Russian Federation
-
Jazz PharmaceuticalsBeiGene, Ltd.Active, not recruitingHER2-amplified Biliary Tract CancersUnited States, Spain, United Kingdom, Korea, Republic of, Canada, China, Italy, Chile, France
-
UNICANCERDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Dorte NielsenTerminated
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Shanghai Changzheng HospitalUnknown
-
Genentech, Inc.Completed
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingBrain Tumor, Recurrent | Brain Tumor, RefractoryUnited States
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Sunnybrook Health Sciences CentreMOUNT SINAI HOSPITAL; Princess Margaret Hospital, Canada; Trillium Health PartnersRecruiting
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Urothelium CancerChina
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
OnkoZentrum Zürich AGUniversity of Zurich; Palleos Healthcare GmbHCompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported OutcomeSwitzerland
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Imugene LimitedActive, not recruitingStomach Cancer | Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Cancer of Stomach | Stomach AdenocarcinomaTaiwan, Australia
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Helsinki University Central HospitalActive, not recruiting
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownPancreatic Cancer | CARChina
-
Genentech, Inc.Completed
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedFirst or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone MetastasisUnited States
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Genentech, Inc.Completed
-
GlaxoSmithKlineWithdrawn
-
Zhimin ShaoRoche Pharma AGUnknownHER-2 Positive Breast CancerChina
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Hengrui Therapeutics, Inc.UnknownBreast Cancer | Gastric Cancer | NSCLC | Solid TumorsUnited States
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast CancerUnited States
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Peking Union Medical College HospitalCompletedBreast CancerChina